EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care

Phillip G Febbo iD, Mina Allo iD, Emma B Alme, Gebra Cuyun Carter iD, Robert Dumanois, Alessia Essig iD, Estevan Kiernan, Caitlin B Kubler, Nikki Martin iD, Medeea C Popescu iD, Lauren C Leiman

JCO Precision Oncology · 2024-02 · (8)

DOI: 10.1200/po.23.00382 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JCO Precision Oncology, 2024-02. Verfasst von Phillip G Febbo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Illumina, San Diego, CA. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liquid biopsies—tests that detect circulating tumor cellular components in the bloodstream—have the potential to transform cancer by reducing health inequities in screening, diagnostics, and monitoring. Today, liquid biopsies are being used to guide treatment choices for patients and monitor for cancer recurrence, and promising work in multi-cancer early detection is ongoing. However, without awareness of the barriers to adoption of this new technology and a willingness to build mitigation efforts into the implementation of widespread liquid biopsy testing, the communities that could most benefit may be the last to access and use them. In this work, we review the challenges likely to affect the accessibility of liquid biopsies in both the general population and underserved populations, and recommend specific actions to facilitate equitable access for all patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Cells, CirculatingHumansLiquid Biopsy

Autor:innen und Institutionen

  • Illumina, San Diego, CA.
  • Tempus, Chicago, IL.
  • Guardant Health, Palo Alto, CA.
  • Exact Sciences, Madison, WI.
  • Thermo Fisher Scientific, Waltham, MA.
  • AstraZeneca, Cambridge, United Kingdom.

ORCID-Profile: Phillip G Febbo, Mina Allo, Gebra Cuyun Carter, Alessia Essig, Nikki Martin, Medeea C Popescu

Zitieren

APA

Febbo, P. G., Allo, M., Alme, E. B., Cuyun Carter, G., Dumanois, R., Essig, A., Kiernan, E., Kubler, C. B., Martin, N., Popescu, M. C., & Leiman, L. C. (2024). Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care. JCO Precision Oncology. https://doi.org/10.1200/po.23.00382

Vancouver

Febbo PG, Allo M, Alme EB, Cuyun Carter G, Dumanois R, Essig A, et al. Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care. JCO Precision Oncology. 2024. doi:10.1200/po.23.00382

BibTeX
@article{Febbo2024,
  author = {Febbo, Phillip G and Allo, Mina and Alme, Emma B and Cuyun Carter, Gebra and Dumanois, Robert and Essig, Alessia and Kiernan, Estevan and Kubler, Caitlin B and Martin, Nikki and Popescu, Medeea C and Leiman, Lauren C},
  title = {Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care},
  journal = {JCO Precision Oncology},
  year = {2024},
  number = {8},
  doi = {10.1200/po.23.00382}
}
Kostenlos starten →